Hofseth BioCare Q3 2026 operating loss narrows 81% year-on-year to NOK 5.7 million

Bitget2026/11/06 07:22

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Hofseth BioCare’s third-quarter 2026 EBITDA turned positive at NOK 4.4 million, versus negative NOK 21.1 million a year earlier.
Total operating revenues climbed 52% year-over-year to a quarterly record of NOK 83.5 million.
Quarter-end cash and cash equivalents totaled NOK 33.6 million, while total liquidity including available credit facilities reached NOK 42.5 million.
Midsund processed 3,349 tonnes of raw material, down 37% year-over-year, with no unplanned production stops.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hofseth BioCare ASA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060215OMX_____CNEWS_EN_GNW1001302120_en) on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Hofseth BioCare Q3 2026 operating loss narrows 81% year-on-year to NOK 5.7 million

You may also like

Crypto prices